
The AcceleDent System is intended for 20 minutes of daily use. Patients bite down on the mouthpiece, which connects to an activator to deliver a light, pulsing force. The AcceleDent System also includes a travel shell and a charging port to recharge the device battery and provide compliance usage information that is captured by a microprocessor in the activator.
While the AcceleDent System is currently sold in the United Kingdom and Australia, it is neither FDA-cleared nor FDA-approved, and is currently investigational only in the United States. OrthoAccel anticipates the conclusion of a US clinical trial at the UT Health Science Center in San Antonio later this year.
For more information about this and other orthodontic companies, visit our Buyer’s Guide.